EE146 Cost-Effectiveness of Axicabtagene Ciloleucel Versus Other CAR T-Cell Therapies in the Treatment of Diffuse Large B-Cell Lymphoma in France

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.398
https://www.valueinhealthjournal.com/article/S1098-3015(22)02602-X/fulltext
Title : EE146 Cost-Effectiveness of Axicabtagene Ciloleucel Versus Other CAR T-Cell Therapies in the Treatment of Diffuse Large B-Cell Lymphoma in France
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02602-X&doi=10.1016/j.jval.2022.09.398
First page :
Section Title :
Open access? : No
Section Order : 12204
Categories :
Tags :
Regions :
ViH Article Tags :